Royalty Pharma Appoints Molly Sawaya as Executive Vice President, Head of Human Capital

Core Insights - Royalty Pharma plc has appointed Molly Sawaya as Executive Vice President, Head of Human Capital, effective July 24, 2024 [1][4] Company Overview - Royalty Pharma, founded in 1996, is the largest buyer of biopharmaceutical royalties and a leading funder of innovation in the biopharmaceutical industry [8] - The company collaborates with various entities, including academic institutions, research hospitals, non-profits, and biotechnology companies, to fund innovation [8] - Royalty Pharma's portfolio includes royalties on over 35 commercial products, such as Vertex's Trikafta and GSK's Trelegy, as well as 17 development-stage product candidates [8] Leadership Appointment - Molly Sawaya brings nearly 15 years of HR experience from large global organizations, focusing on creating environments for employee growth and engagement [4][7] - Prior to joining Royalty Pharma, Sawaya was a Managing Director at Hudson Bay Capital, where she led the HR agenda [7] - The CEO of Royalty Pharma, Pablo Legorreta, expressed confidence in Sawaya's ability to enhance the company's culture and support its growth [4]